Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed Nov 9, 2012 · 10-Q · 40 days after period end · 0001193125-12-463729
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $0.00 | — | — |
| Net Income | -$2.25M | -$3.51M | -$13.54M |
| EPS Diluted | -$1.56 | -$0.25 | -$3.47 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 9, 2012 · 40 d after period end
